Research location
Yeovil
United Kingdom
Advertisement
Research activity in Yeovil
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 21 trials and 21 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Yeovil
21 linked trials · page 1 of 1Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary DiseaseNCT06347536 · 2025-01-30 · 1 site observation
RECRUITING
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)NCT05085028 · 2022-06-23 · 1 site observation
RECRUITING
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNCT04109079 · 2021-02-26 · 1 site observation
RECRUITING
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis StudyNCT04204915 · 2020-03-10 · 1 site observation
RECRUITING
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.NCT02102165 · 2014-04-01 · 1 site observation
RECRUITING
CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)NCT04226248 · 2020-01-02 · 1 site observation
COMPLETED
Rostock International Parkinson's Disease Study (ROPAD)NCT03866603 · 2019-05-30 · 1 site observation
COMPLETED
An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast CancerNCT03099200 · 2016-12-12 · 1 site observation
COMPLETED
Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's DiseaseNCT02787590 · 2016-03-08 · 1 site observation
COMPLETED
Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry StudyNCT02393924 · 2015-02-23 · 1 site observation
COMPLETED
Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung CancersNCT02423590 · 2014-06-01 · 1 site observation
UNKNOWN
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast CancerNCT02423603 · 2014-05-14 · 1 site observation
COMPLETED
A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast CancerNCT02120417 · 2014-05-01 · 1 site observation
TERMINATED
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast CancerNCT01966471 · 2014-01-31 · 1 site observation
COMPLETED
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast CancerNCT02216786 · 2014-01-16 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentNCT01702571 · 2012-11-27 · 1 site observation
COMPLETED
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)NCT01147250 · 2010-06-01 · 1 site observation
COMPLETED
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With HerceptinNCT01152606 · 2007-08-30 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT00806923 · 2005-02-01 · 1 site observation
COMPLETED
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In SituNCT00072462 · 2003-09-01 · 1 site observation
COMPLETED
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast CancerNCT00078832 · 2003-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.